Mirex Genomics is a newly established bioinformatic analysis partnership that caters for scientific researchers (UK and international) with custom computational needs. It specialises in transcriptomics (single cell RNA-Seq, bulk RNA-Seq) and gene ontology analysis as well as specialised next generation (NGS) techniques, such as SNS-Seq or ChIP-Seq. Mirex Genomics also caters for custom phylogenomic analysis pipelines and custom software development.
For further info, please contact: zehra.akerman@gmail.com
Company Details
- Founded
- 2022
- Address
- Birmingham, Gb
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- gene ontology analysis, next generation (NGS) techniques, SNS-Seq, ChIP-Seq, custom phylogenomic analysis pipelines, custom software development, and Transcriptomics (single cell RNA-Seq, bulk RNA-Seq).
- HQ
- Birmingham
Mirex Genomics Questions
Mirex Genomics's LinkedIn profile is https://uk.linkedin.com/company/mirex-genomics
Mirex Genomics's industry is
Research Services
Mirex Genomics's top competitors are
Exela Technologies,
Salus Biomed,
Parse Biosciences,
Molecular Health,
Shodhaka Life Sciences,
Mirex Technologies,
Salus Biomed Europe.
Mirex Genomics's categories are Research Services
Mirex Genomics's founding year is 2022
